Your browser doesn't support javascript.
loading
Outcomes with retrograde versus antegrade chronic total occlusion revascularization.
Megaly, Michael; Ali, Abdelrahman; Saad, Marwan; Omer, Mohamed; Xenogiannis, Iosif; Werner, Gerald S; Karmpaliotis, Dimitri; Russo, Juan J; Yamane, Masahisa; Garbo, Roberto; Gagnor, Andrea; Ungi, Imre; Rinfret, Stephane; Pershad, Ashish; Wojcik, Jaroslaw; Garcia, Santiago; Mashayekhi, Kambis; Sianos, Georgios; Galassi, Alfredo R; Burke, M Nicholas; Brilakis, Emmanouil S.
Afiliación
  • Megaly M; Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota.
  • Ali A; Department of Cardiovascular Medicine, Hennepin Healthcare, Minneapolis, Minnesota.
  • Saad M; Department of Medicine, Mercy Hospital and Medical Center, Chicago, Illinois.
  • Omer M; Division of Cardiovascular Medicine, The Warren Alpert School of Medicine at Brown University, Providence, Rhode Island.
  • Xenogiannis I; Department of Cardiovascular Medicine, Ain Shams University Hospitals, Cairo, Egypt.
  • Werner GS; Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota.
  • Karmpaliotis D; Department of Cardiovascular Medicine, Hennepin Healthcare, Minneapolis, Minnesota.
  • Russo JJ; Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota.
  • Yamane M; Medizinische Klinik I (Cardiology and Intensive Care), Klinikum Darmstadt GmbH, Darmstadt, Germany.
  • Garbo R; Department of Cardiology, Columbia University, New York, New York.
  • Gagnor A; Department of Cardiology, Columbia University, New York, New York.
  • Ungi I; Department of Cardiology, Sayama Hospital, Saitama, Japan.
  • Rinfret S; Department of Invasive Cardiology, San Giovanni Bosco Hospital, Turin, Italy.
  • Pershad A; Department of Invasive Cardiology, Maria Vittoria Hospital, Turin, Italy.
  • Wojcik J; Division of Invasive Cardiology, University of Szeged, Second Department of Internal Medicine and Cardiology Center, Szeged, Hungary.
  • Garcia S; Division of Interventional Cardiology, McGill University Health Centre, Montreal, Canada.
  • Mashayekhi K; Division of Cardiology, Banner-University Medical Center, Phoenix, Arizona.
  • Sianos G; Department of Cardiology, Hospital of Invasive Cardiology IKARDIA, Naleczów, Poland.
  • Galassi AR; Minneapolis Heart Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota.
  • Burke MN; Division of Cardiology and Angiology II, University Heart Center Freiburg-Bad Krozingen, Bad Krozingen, Germany.
  • Brilakis ES; First Department of Cardiology, AHEPA University Hospital, Thessaloniki, Greece.
Catheter Cardiovasc Interv ; 96(5): 1037-1043, 2020 11.
Article en En | MEDLINE | ID: mdl-31778041
ABSTRACT

OBJECTIVES:

The aim of the study was to evaluate the outcomes of retrograde versus antegrade approach in chronic total occlusion (CTO) percutaneous coronary intervention (PCI).

BACKGROUND:

The retrograde approach has increased the success rate of CTO PCI but has been associated with a higher risk for complications.

METHODS:

We conducted a meta-analysis of studies published between 2000 and August 2019 comparing the in-hospital and long-term outcomes with retrograde versus antegrade CTO PCI.

RESULTS:

Twelve observational studies (10,240 patients) met our inclusion criteria (retrograde approach 2,789 patients, antegrade approach 7,451 patients). Lesions treated with the retrograde approach had higher J-CTO score (2.8 vs. 1.9, p < .001). Retrograde CTO PCI was associated with a lower success rate (80.9% vs. 87.4%, p < .001). Both approaches had similar in-hospital mortality, urgent revascularization, and cerebrovascular events. Retrograde CTO PCI was associated with higher risk of in-hospital myocardial infarction (MI; odds ratio [OR] 2.37, 95% confidence intervals [CI] 1.7, 3.32, p < .001), urgent pericardiocentesis (OR 2.53, 95% CI 1.41-4.51, p = .002), and contrast-induced nephropathy (OR 2.12, 95% CI 1.47-3.08; p < .001). During a mean follow-up of 48 ± 31 months retrograde crossing had similar mortality (OR 1.79, 95% CI 0.84-3.81, p = .13), but a higher incidence of MI (OR 2.07, 95% CI 1.1-3.88, p = .02), target vessel revascularization (OR 1.92, 95% CI 1.49-2.46, p < .001), and target lesion revascularization (OR 2.08, 95% CI 1.33-3.28, p = .001).

CONCLUSIONS:

Compared with antegrade CTO PCI, retrograde CTO PCI is performed in more complex lesions and is associated with a higher risk for acute and long-term adverse events.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oclusión Coronaria / Intervención Coronaria Percutánea Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Catheter Cardiovasc Interv Asunto de la revista: CARDIOLOGIA Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Oclusión Coronaria / Intervención Coronaria Percutánea Tipo de estudio: Etiology_studies / Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: Catheter Cardiovasc Interv Asunto de la revista: CARDIOLOGIA Año: 2020 Tipo del documento: Article